Latest Cord blood bank Stories
BOTHELL, Wash., Oct. 29, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced the Company's novel biopreservation technology is being used in more than 50 clinical trial-stage cellular therapies, making it the leading choice in the emerging, high growth field of...
COVINA, Calif., Oct. 25, 2012 /PRNewswire/ -- StemCyte, Inc. is proud to announce that StemCyte Taiwan has met the eligibility requirements for accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT), an organization helping to assure the highest standards in cellular therapy practices. StemCyte Taiwan's accreditation achievement matches its continued FACT accreditation at its Covina, California North American lab. The dual lab accreditation is further...
HONG KONG, Oct. 22, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company will hold its annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 19, 2012 (8:00 a.m. U.S. Eastern Time on December 19, 2012). Shareholders of record as of...
HONG KONG, Oct. 22, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company repurchased an aggregate of 6,041,980 ordinary shares for a total consideration of approximately $16.4 million since April 1, 2012. The total number of shares issued and outstanding as of the date hereof is 73,140,147, with 6,041,980 shares being held as treasury shares. On...
“The US Blood Banking Market: Test Volume and Reagent Sales Forecasts by Market Segment, Key Supplier Shares” and “Complete 2012 U.S. Cord Blood Banking Industry Report” market research reports have been added to the database of ReportsnReports.com. Dallas, TX (PRWEB) October 20, 2012 “The US Blood Banking Market: Test Volume and Reagent Sales Forecasts by Market Segment, Key Supplier Shares” and “Complete 2012 U.S. Cord Blood Banking Industry Report” market research...
HONG KONG, Oct. 3, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, announced that it has successfully completed the previously announced $50 million convertible note financing with Golden Meditech Holdings Limited ("Golden Meditech", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China and the Company's largest shareholder. The board of directors of CCBC...
NEWTON, Mass., Sept. 18, 2012 /PRNewswire/ -- New England Cord Blood Bank, Inc. (NECBB) is pleased to announce that it now processes its cord blood using the Sepax 2 system from Biosafe. Biosafe is the world leader in stem cell processing, serving stem cell banks, hospitals and research institutes alike with innovative cell processing solutions. Sepax 2 is a fully automated, mobile, closed capability system that provides the most efficient and consistent processing of umbilical...
HONG KONG, Sept. 18, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China and Golden Meditech Holdings Limited ("Golden Meditech", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China announced that they entered into agreements under which Golden Meditech, is expected to invest $50 million into CCBC to support its further business expansion and to capitalize on...
BOTHELL, Wash., Sept. 12, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced its participation at the IBC Inaugural Cell Therapy Clinical Development Conference taking place this week in Arlington, VA. (Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)...
HONG KONG, Aug. 17, 2012 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("the Company") today announced its plan to release financial results for the first quarter of fiscal year 2013 on Wednesday, August 22, 2012, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Thursday, August 23, 2012 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and...
